BMO Capital Markets Cuts Corteva (NYSE:CTVA) Price Target to $95.00

Corteva (NYSE:CTVA) had its price target reduced by equities research analysts at BMO Capital Markets from $100.00 to $95.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. BMO Capital Markets’ price target would indicate a potential upside of 13.87% from the stock’s current price.

A number of other analysts have also weighed in on CTVA. JPMorgan Chase & Co. raised their target price on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Citigroup upped their price target on shares of Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Royal Bank Of Canada reiterated an “outperform” rating and issued a $103.00 price target on shares of Corteva in a research note on Wednesday. Mizuho boosted their price objective on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. Finally, Barclays increased their target price on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $91.50.

Corteva Trading Up 1.1%

Shares of CTVA opened at $83.43 on Wednesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva has a 52-week low of $60.53 and a 52-week high of $90.97. The firm has a market cap of $55.66 billion, a price-to-earnings ratio of 55.25, a PEG ratio of 2.53 and a beta of 0.57. The business’s fifty day moving average is $83.35 and its 200-day moving average is $81.44.

Corteva (NYSE:CTVA) last released its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts anticipate that Corteva will post 3.72 EPS for the current fiscal year.

Hedge Funds Weigh In On Corteva

Institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in Corteva in the second quarter worth $4,560,180,000. Franklin Resources Inc. increased its position in Corteva by 4.3% in the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after buying an additional 805,873 shares in the last quarter. Independent Franchise Partners LLP boosted its holdings in Corteva by 1.0% in the fourth quarter. Independent Franchise Partners LLP now owns 10,495,388 shares of the company’s stock worth $703,506,000 after acquiring an additional 107,434 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Corteva by 941.7% during the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after acquiring an additional 6,881,875 shares in the last quarter. Finally, Royal Bank of Canada raised its position in shares of Corteva by 202.1% during the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after purchasing an additional 4,989,371 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Key Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Spinoff formally approved: Corteva’s board approved the distribution of Vylor, advancing the company’s plan to create two independent, publicly traded businesses. The separation could allow Corteva’s crop-protection operations and Vylor’s seed business to pursue more focused strategies. Corteva Board of Directors Approves Vylor Distribution
• Positive Sentiment: Seed technology offers long-term growth: Vylor said its hybrid wheat platform, marketed as Xpedite, is expected to launch in late 2027. The company forecasts approximately $500 million in North American wheat revenue by 2035 and $1 billion by 2040. Vylor Confirms Breakthrough Wheat Technology Will Launch in 2027
• Positive Sentiment: Expanded soybean strategy: Vylor plans four technology platforms by 2035, including broader-spectrum insect control in Latin America, and expects roughly $500 million of incremental revenue by 2035. The initiatives support the investment case for Corteva’s seed assets ahead of the separation. Vylor to Expand Soybean Leadership
• Neutral Sentiment: Investor Day provided additional detail on the separation, innovation pipeline and long-term strategy, but the supplied update does not include specific new FY 2029 EPS figures. Corteva Analyst/Investor Day Transcript
• Negative Sentiment: Regulatory and litigation uncertainty remains: Several state attorneys general are seeking to block the corporate separation. Corteva rejected their allegations as unfounded, but the dispute could delay the October 1 transaction or increase execution costs. Corteva Rejects State Attorneys General Allegations

About Corteva

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.